201 related articles for article (PubMed ID: 7908027)
1. Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo.
Kruse B; Hanefeld F; Christen HJ; Bruhn H; Michaelis T; Hänicke W; Frahm J
J Neurol; 1993 Dec; 241(2):68-74. PubMed ID: 7908027
[TBL] [Abstract][Full Text] [Related]
2. MR-spectroscopy in metachromatic leukodystrophy: A model free approach and clinical correlation.
Feldmann J; Martin P; Bender B; Laugwitz L; Zizmare L; Trautwein C; Krägeloh-Mann I; Klose U; Groeschel S
Neuroimage Clin; 2023; 37():103296. PubMed ID: 36563646
[TBL] [Abstract][Full Text] [Related]
3. Quantitative MR spectroscopic imaging in metachromatic leukodystrophy: value for prognosis and treatment.
van Rappard DF; Klauser A; Steenweg ME; Boelens JJ; Bugiani M; van der Knaap MS; Wolf NI; Pouwels PJW
J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):105-111. PubMed ID: 28889092
[TBL] [Abstract][Full Text] [Related]
4. MR imaging and localized proton MR spectroscopy in late infantile neuronal ceroid lipofuscinosis.
Seitz D; Grodd W; Schwab A; Seeger U; Klose U; Nägele T
AJNR Am J Neuroradiol; 1998 Aug; 19(7):1373-7. PubMed ID: 9726485
[TBL] [Abstract][Full Text] [Related]
5. Brain N-acetylaspartate levels correlate with motor function in metachromatic leukodystrophy.
i Dali C; Hanson LG; Barton NW; Fogh J; Nair N; Lund AM
Neurology; 2010 Nov; 75(21):1896-903. PubMed ID: 21098404
[TBL] [Abstract][Full Text] [Related]
6. Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal ceroid lipofuscinosis.
Brockmann K; Pouwels PJ; Christen HJ; Frahm J; Hanefeld F
Neuropediatrics; 1996 Oct; 27(5):242-8. PubMed ID: 8971744
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy of human brain: applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities.
Sappey-Marinier D; Calabrese G; Hetherington HP; Fisher SN; Deicken R; Van Dyke C; Fein G; Weiner MW
Magn Reson Med; 1992 Aug; 26(2):313-27. PubMed ID: 1513253
[TBL] [Abstract][Full Text] [Related]
8. Cerebral proton magnetic resonance spectroscopy in infantile Alexander disease.
Brockmann K; Dechent P; Meins M; Haupt M; Sperner J; Stephani U; Frahm J; Hanefeld F
J Neurol; 2003 Mar; 250(3):300-6. PubMed ID: 12638020
[TBL] [Abstract][Full Text] [Related]
9. Human fetal brain chemistry as detected by proton magnetic resonance spectroscopy.
Brighina E; Bresolin N; Pardi G; Rango M
Pediatr Neurol; 2009 May; 40(5):327-42. PubMed ID: 19380068
[TBL] [Abstract][Full Text] [Related]
10. High-resolution magic angle spinning and 1H magnetic resonance spectroscopy reveal significantly altered neuronal metabolite profiles in CLN1 but not in CLN3.
Sitter B; Autti T; Tyynelä J; Sonnewald U; Bathen TF; Puranen J; Santavuori P; Haltia MJ; Paetau A; Polvikoski T; Gribbestad IS; Häkkinen AM
J Neurosci Res; 2004 Sep; 77(5):762-9. PubMed ID: 15352223
[TBL] [Abstract][Full Text] [Related]
11. Proton MRS profile of cerebral metabolic abnormalities in Krabbe disease.
Brockmann K; Dechent P; Wilken B; Rusch O; Frahm J; Hanefeld F
Neurology; 2003 Mar; 60(5):819-25. PubMed ID: 12629240
[TBL] [Abstract][Full Text] [Related]
12. Short echo time proton spectroscopy of human brain using a gradient head coil.
Majors A; Xue M; Ng TC; Modic MT
Magn Reson Imaging; 1992; 10(4):649-54. PubMed ID: 1354323
[TBL] [Abstract][Full Text] [Related]
13. Direct absolute quantification of metabolites in the human brain with in vivo localized proton spectroscopy.
Hennig J; Pfister H; Ernst T; Ott D
NMR Biomed; 1992; 5(4):193-9. PubMed ID: 1449955
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.
Arnold DL; Matthews PM; Francis GS; O'Connor J; Antel JP
Ann Neurol; 1992 Mar; 31(3):235-41. PubMed ID: 1637131
[TBL] [Abstract][Full Text] [Related]
15. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.
Chang L; Ernst T; Speck O; Grob CS
Am J Psychiatry; 2005 Feb; 162(2):361-9. PubMed ID: 15677602
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance spectroscopy and magnetic resonance imaging findings in Krabbe's disease.
Zarifi MK; Tzika AA; Astrakas LG; Poussaint TY; Anthony DC; Darras BT
J Child Neurol; 2001 Jul; 16(7):522-6. PubMed ID: 11453451
[TBL] [Abstract][Full Text] [Related]
17. High-field localized 1H NMR spectroscopy in the anesthetized and in the awake monkey.
Pfeuffer J; Juchem C; Merkle H; Nauerth A; Logothetis NK
Magn Reson Imaging; 2004 Dec; 22(10):1361-72. PubMed ID: 15707786
[TBL] [Abstract][Full Text] [Related]
18. Molar quantitation of in vivo proton metabolites in human brain with 3D magnetic resonance spectroscopic imaging.
Husted CA; Duijn JH; Matson GB; Maudsley AA; Weiner MW
Magn Reson Imaging; 1994; 12(4):661-7. PubMed ID: 8057771
[TBL] [Abstract][Full Text] [Related]
19. Metabolic changes in the vicinity of brain contusions: a proton magnetic resonance spectroscopy and histology study.
Schuhmann MU; Stiller D; Skardelly M; Bernarding J; Klinge PM; Samii A; Samii M; Brinker T
J Neurotrauma; 2003 Aug; 20(8):725-43. PubMed ID: 12965052
[TBL] [Abstract][Full Text] [Related]
20. T1, T2, and concentrations of brain metabolites in neonates and adolescents estimated with H-1 MR spectroscopy.
Toft PB; Christiansen P; Pryds O; Lou HC; Henriksen O
J Magn Reson Imaging; 1994; 4(1):1-5. PubMed ID: 7908545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
